How to Take Glucosamine and Chondroitin: Dosage, Timing and Duration
Glucosamine and chondroitin are among the best-selling joint supplements in the UK, popular with runners, lifters and older adults with knee pain. They are also among the most argued about: some trials show modest benefits, others none, and NICE does not recommend them for osteoarthritis on the NHS. If you decide to try them anyway, using them in the way studies did gives the fairest test. Our editorial team explains doses, timing, duration and safety.
What these compounds are
Glucosamine is an amino sugar that the body uses to build glycosaminoglycans, the long chain molecules that give cartilage its ability to hold water and resist compression. Supplements are usually made from shellfish shells or, increasingly, by fermentation of corn, and come as glucosamine sulfate or glucosamine hydrochloride.
Chondroitin sulfate is itself a glycosaminoglycan, a major component of cartilage. Commercial chondroitin is extracted from bovine, porcine, chicken or shark cartilage. Its quality varies considerably, and analyses of products have found discrepancies between labelled and actual content.
The rationale is that providing these building blocks may support cartilage metabolism and reduce the breakdown seen in osteoarthritis. Laboratory studies also suggest mild anti-inflammatory effects. How much of an oral dose reaches joint cartilage intact remains debated.
In Great Britain these products are sold as food supplements, though some glucosamine products have previously been licensed as medicines. No health claims for joint health have been authorised on the GB register.
Dosage used in research
Clinical trials have used fairly consistent doses, which provide a sensible reference point:
| Ingredient | Daily amount in studies | Notes |
|---|---|---|
| Glucosamine sulfate | 1,500 mg | Most positive trials used crystalline glucosamine sulfate |
| Glucosamine hydrochloride | 1,500 mg | Used in the large US GAIT trial; weaker evidence |
| Chondroitin sulfate | 800–1,200 mg | Pharmaceutical-grade products in European trials |
| Combination | 1,500 mg + 1,200 mg | As in GAIT and the MOVES trial |
Products providing a fraction of these amounts — for example, 250 mg glucosamine per tablet with a "take one daily" instruction — are unlikely to reproduce study outcomes. Check the amount per daily serving, not per tablet.
Higher doses have not been shown to work better. Doubling the dose increases cost and the chance of digestive side effects without evidence of extra benefit.
The form matters more for glucosamine than for chondroitin. If you choose glucosamine, the sulfate form has the more supportive research base.
When and how to take them
Timing is flexible. Studies have used either a single daily dose or divided doses, typically two or three times a day with meals. There is no strong evidence that one approach is superior.
Practical tips:
- take with food to reduce the chance of nausea, heartburn or loose stools;
- choose once-daily dosing if it improves consistency, as missing doses is the real enemy;
- powdered glucosamine sulfate sachets dissolve in water and suit people who dislike large tablets;
- keep other supplements, such as omega-3 or collagen, separate in your mind — they are not substitutes.
There is no need to time these supplements around training. They are not acute performance aids, and any effect builds over weeks.
Combination products with added MSM, turmeric, vitamin C or hyaluronic acid are common. Some extras have limited evidence of their own, but combinations make it harder to know what, if anything, is helping.
How long before judging the effect
Trials showing benefit for pain typically ran for at least three months, and structural studies lasted two to three years. Effects, where present, tend to be gradual.
A pragmatic approach is a three-month trial at a research dose, keeping a simple pain and function diary. If there is no noticeable improvement by then, continuing is unlikely to be worthwhile.
Bear in mind that knee pain fluctuates naturally and responds to changes in training, weight and footwear. A placebo response is substantial in osteoarthritis trials, so improvements should be interpreted cautiously.
NICE guideline NG226 (2022) advises against offering glucosamine for osteoarthritis because of insufficient evidence of benefit, while emphasising exercise, weight management and education. Supplements, if used, should be an addition to these measures, not a replacement.
Safety, interactions and who should avoid them
Both supplements are generally well tolerated. The most common side effects are mild digestive complaints: nausea, indigestion, diarrhoea or constipation. Allergic reactions are uncommon.
Glucosamine derived from shellfish may be unsuitable for people with shellfish allergy; fermentation-derived products are an alternative, but check with a doctor if your allergy is severe. Vegetarians and vegans should note that chondroitin is animal-derived.
Glucosamine, with or without chondroitin, has been reported to enhance the effect of warfarin, increasing INR and bleeding risk. Anyone on warfarin should avoid these supplements unless their anticoagulation clinic agrees and monitors closely.
People with diabetes, asthma, kidney disease, those who are pregnant or breastfeeding, and anyone awaiting surgery should consult a GP or pharmacist first. Persistent joint pain, swelling, locking or instability in an athlete needs clinical assessment rather than supplements alone.
Editorial team's conclusions
If you choose to try glucosamine and chondroitin, use doses that match research — around 1,500 mg glucosamine sulfate and 800–1,200 mg chondroitin daily — take them with food, and give them about three months before deciding. Expect modest results at best, prioritise exercise and load management, and check for interactions, especially with warfarin.
Related topics you may find useful include collagen peptides and tendon health, omega-3 fatty acids for joint pain, and how to manage knee pain in runners.
References
- Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795–808.
- Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357(9252):251–256.
- Hochberg MC, Martel-Pelletier J, Monfort J, et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016;75(1):37–44.
- Wandel S, Jüni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010;341:c4675.
- National Institute for Health and Care Excellence. Osteoarthritis in over 16s: diagnosis and management (NICE guideline NG226). London: NICE; 2022.
- Knudsen JF, Sokol GH. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. Pharmacotherapy. 2008;28(4):540–548.
